
AB SCIENCE Investor Relations Material
Latest events

Status Update
AB SCIENCE
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AB SCIENCE
Access all reports
AB Science is a biotechnology company specializing in the research, development, and commercialization of targeted therapies for serious diseases. The company focuses on small molecule drugs designed to address conditions in oncology, neurodegenerative disorders, and inflammatory diseases. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
AB
Country
🇫🇷 France